RxDoctor Payments Data

James Bradner

Hematology & Oncology · Boston, MANPI 1518920867

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Amgen. That places this record below the midpoint for hematology & oncology clinicians in MA, where the typical reported total is $856.

$118in general payments, 2019–2025

Across 2 payments — averaging $58.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$118
$617,853in research payments, 2019–2025

Across 4 payments — averaging $154,463 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$618K

What the payments were for

  • Food & beverage$118100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen2$118

How this compares

$118 in reported general payments places this provider in the 25th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts →

Other hematology & oncology in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →